Mechanistic basis of post-treatment control of SIV after anti-α4β7 antibody therapy.
Treating macaques with an anti-α4β7 antibody under the umbrella of combination antiretroviral therapy (cART) during early SIV infection can lead to viral remission, with viral loads maintained at < 50 SIV RNA copies/ml after removal of all treatment in a subset of animals. Depletion of CD8+ lymph...
Saved in:
| Main Authors: | Chad R Wells, Youfang Cao, David P Durham, Siddappa N Byrareddy, Aftab A Ansari, Nancy H Ruddle, Jeffrey P Townsend, Alison P Galvani, Alan S Perelson |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-06-01
|
| Series: | PLoS Computational Biology |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189501 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SIV proviruses seeded later in infection are harbored in short-lived CD4+ T cells
by: Narmada Sambaturu, et al.
Published: (2025-05-01) -
Mechanistic basis of atypical TERT promoter mutations
by: Kerryn Elliott, et al.
Published: (2024-11-01) -
SIV Env RhmAbs + N-803 at ART initiation prolongs viral decay without disrupting reservoir establishment in SIV-infected infant macaques.
by: Omotayo Farinre, et al.
Published: (2025-01-01) -
Combining a rhesus cytomegalovirus/SIV vaccine with a neutralizing antibody to protect against SIV challenges in rhesus macaques
by: Jessica Coppola, et al.
Published: (2025-06-01) -
SIV vpx is essential for macrophage infection but not for development of AIDS.
by: Susan V Westmoreland, et al.
Published: (2014-01-01)